The most interesting thread running through this horse's career is what happens at Lingfield Park. Two wins from 6 races there — winning 1 in every 3 — stands out sharply against a much tighter 1 win from 12 races (8%) at Class 5 level overall. Something about Lingfield suits Solar Edge in a way that most tracks simply don't. Whether it's the tight turns, the synthetic surface, or just the trip, the numbers say this is a horse worth noting whenever Lingfield appears on the schedule.
The partnership with jockey Gina Mangan is another reason to pay attention. In 11 races together, they've won 3 times — that's 27%, or just over 1 in every 4 rides — which is a meaningfully better return than Solar Edge's overall career average. When Mangan is booked, the horse runs like a different animal. Christopher Mason's yard has sent out 12 winners this season, so there's clearly no shortage of confidence in the operation, and that Mangan-Mason combination looks like one worth tracking.
Recent form reads 7-2-1-5-2-9 from the last six races, which tells an interesting story. A win, two runner-up finishes, and another placing are buried inside those six runs — Solar Edge finished in the top two as recently as the race before last, and won at Bath on 27 April 2026 just two months ago. The horse raced only yesterday, so it is as current and competitive as they come right now. The disappointing 9th and 7th either side of those good efforts suggest Solar Edge can run below its best when conditions don't fall right, but when everything clicks — especially at Lingfield — this is a horse that knows exactly how to win.
| Course | Races | Results | Last visited | Win rate |
|---|---|---|---|---|
| Lingfield Park Sharp |
6 | 2 wins, 1 second, 3 other | 6 Jul | 33.3% |
| Bath Undulating |
4 | 1 win, 1 third, 2 other | 27 Apr | 25% |
| Windsor Sharp |
4 | 2 seconds, 2 other | 1 Jun | 0% |
| Chepstow Galloping |
2 | 1 win, 1 other | 26 Aug | 50% |
| Wolverhampton Galloping |
2 | 1 second, 1 other | 8 Nov | 0% |
| Southwell Galloping |
1 | 1 other | 13 Dec | 0% |